Rhea is a graduate student in the Biological and Biomedical Sciences (BBS) PhD program and joined the Cichowski lab in the fall of 2021. She is currently characterizing combination therapies that synergize with EZH2 inhibition in prostate cancer. Outside of lab, she enjoys dancing, exploring new places and activities with friends and family, reading, watching television/movies, and consuming large quantities of chocolate desserts.